Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs BeyondMD

AquaVita NextGen
Graded #421

Lower grade

vs+10.399999999999999
BeyondMD
Graded #189

Higher grade

The verdict

BeyondMD takes it — 66.5/100 to 56.1/100.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +53
22
75
Dose & formulationAquaVita NextGen +11
75
64
Clinical oversightAquaVita NextGen +8
82
74
Labs & monitoringEven
53
53
FulfillmentBeyondMD +3
62
65
Contract termsBeyondMD +8
47
55
AquaVita NextGen · left barBeyondMD · right bar

The numbers

MetricAquaVita NextGenBeyondMD
WeighScore56.1/10066.5/100
GradeCC
Scorecard rank#421#189
Semaglutide$375/mo (first-month rate, compounded)$139/mo (starting dose, compounded)
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)$209/mo (starting dose, compounded)
Coverage5 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
AquaVita NextGen

Graded #421 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
BeyondMD

Graded #189 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard